This HTML5 document contains 99 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.1023/A:
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73356010
rdf:type
wikibase:Item
schema:description
scientific article published on 01 November 2000 наукова стаття, опублікована в листопаді 2000 im November 2000 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en payares de 2000 article scientifique publié en novembre 2000 wetenschappelijk artikel
p:P577
wds:Q73356010-5D9C4B75-2753-4EF8-A927-C359D736E02A
wdt:P577
2000-11-01T00:00:00Z
p:P2860
wds:Q73356010-0ECE8311-45A1-480A-A921-52559C0D4A8E wds:Q73356010-112604B2-DA5D-437B-AEE6-53AF56D11B59 wds:Q73356010-1A01FBF9-F017-4057-8A0C-F41B5F5FBEE0 wds:Q73356010-68651C29-027E-44A2-8A39-1D5786A5357B wds:Q73356010-6AF1B829-6F02-454D-82B3-AB7E6146E8BC wds:Q73356010-73292608-2309-4AA6-9409-B079EB82B220 wds:Q73356010-58729056-D28B-4473-847B-B7EC725046FC wds:Q73356010-4564368B-EB70-4C6E-AD1C-F1E6CE5DFCB7 wds:Q73356010-4E3988F3-2862-47DC-AA11-C54FAF7F841F wds:Q73356010-31A9CB39-E979-44A8-B874-1809207F9E51 wds:Q73356010-351108D7-7181-4203-AB49-F14EE90D53CB wds:Q73356010-CA68B3FA-5E7B-4899-8FA6-EF4D92F16474 wds:Q73356010-E1CA02F7-C09C-44C9-BD72-750CBBE129BF wds:Q73356010-E80C56EA-51AF-44A1-BAC2-5345B85E35BA wds:Q73356010-B8F4E075-DF8E-4D82-BA98-C4281F1EDF11 wds:Q73356010-9D9AE469-5830-40AC-BB37-32EC7F31C1F2 wds:Q73356010-A1B1862F-2622-41AF-819F-8C64853AC3DF wds:Q73356010-75E83340-DD0C-4373-868E-52477E38D107 wds:Q73356010-7EFCFED5-B028-4FCC-9AB0-49F3BDAFA712 wds:Q73356010-98745915-0CF4-447F-B425-C52ACBF36E56 wds:Q73356010-F285DAB8-4749-48F3-81DE-B609B6325A09 wds:Q73356010-FBDFC3BA-899E-4F8D-8914-388D66D2B476 wds:Q73356010-FE385362-69DC-4AF3-8F19-438ABC5A01A0
wdt:P2860
wd:Q55066485 wd:Q34754672 wd:Q40959482 wd:Q74593436 wd:Q67504713 wd:Q72732640 wd:Q43645955 wd:Q33810043 wd:Q33498655 wd:Q72426661 wd:Q40995855 wd:Q29620070 wd:Q41314665 wd:Q61868290 wd:Q35977364 wd:Q33330597 wd:Q70222887 wd:Q74121312 wd:Q38295053 wd:Q47842166 wd:Q71604258 wd:Q42540384 wd:Q28036747
p:P2093
wds:Q73356010-A2EFC4CF-7AB2-4734-9798-93BC1DA227A4 wds:Q73356010-CFC98991-1E37-42D2-89BA-F5C6ECF3B628 wds:Q73356010-9210CE4D-7665-4165-9FAA-1B4D811C9DFE wds:Q73356010-9BB0E8A3-9117-4E5C-94F3-516899FCCF7E wds:Q73356010-5CF30D02-C775-4CA9-80FD-45E2C76DAB75 wds:Q73356010-59D71F13-0A5C-402C-A30A-92C8C5054987 wds:Q73356010-61843C72-0FFB-4EAA-809A-467C45FBECF8 wds:Q73356010-2A71937B-EE82-418A-A30C-C8E8E9660DF0 wds:Q73356010-565E6A45-6E02-45B7-A329-C20CD04FC4FD
wdt:P2093
J M Tigaud J Marceau-Suissa J L Misset M Di Palma M Gross-Goupil F Goldwasser E Cvitkovic A Yovine E Wasserman
rdfs:label
Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients
skos:prefLabel
Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients
schema:name
Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients
p:P1476
wds:Q73356010-F6514486-4362-42BA-9737-9023FC7A8CEF
wdt:P1476
Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: a phase I study in advanced gastrointestinal cancer patients
p:P304
wds:Q73356010-AF4DA8B8-52BA-432A-A2C0-6063B2A96F5D
wdt:P304
1463-1470
p:P31
wds:Q73356010-38339EDE-9CCF-487A-BCB1-E500DA83E227
wdt:P31
wd:Q13442814
p:P921
wds:Q73356010-029888A3-8A2F-415A-B215-C04D25EE2943
wdt:P921
wd:Q422327
p:P698
wds:Q73356010-021F0094-48BB-4B02-AB49-07003FC1EB93
wdtn:P698
n10:11142487
wdt:P698
11142487
p:P1433
wds:Q73356010-535D02AB-236B-4B98-85AD-F3B94C3F3703
wdt:P1433
wd:Q326122
p:P433
wds:Q73356010-AC7F92F7-9F15-4B50-99A5-992BE5E6D4DE
p:P478
wds:Q73356010-1B21337E-255D-48BC-AD88-D1D2B6F379F1
wdt:P433
11
wdt:P478
11
p:P356
wds:Q73356010-9DE9C571-CDFE-43D1-A3DF-C174CD841AE2
wdtn:P356
n8:1026535824044
wdt:P356
10.1023/A:1026535824044